Alloy Therapeutics was named a 2026 Prix Galien USA nominee in the Best Startup category, recognizing emerging companies developing innovative approaches to healthcare and life sciences. The nomination highlights Alloy’s work supporting biopharmaceutical innovation through its integrated drug discovery and development platform, which provides researchers and biotech companies with access to scientific capabilities, infrastructure, and collaborative resources. The 2026 Prix Galien USA winners will be announced at the Prix Galien USA Awards Ceremony on October 29, 2026, at the American Museum of Natural History in New York City.
